Order Article Reprints

Szoltysek K, Ciardullo C, Zhou P, Walaszczyk A, Willmore E, Rand V, Marshall S, Hall A, J. Harrison C, Eswaran J, et al. DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. 2020; 21(20):7663. https://doi.org/10.3390/ijms21207663

Szoltysek, Katarzyna, Carmela Ciardullo, Peixun Zhou, Anna Walaszczyk, Elaine Willmore, Vikki Rand, Scott Marshall, Andy Hall, Christine J. Harrison, Jeyanthy Eswaran, and et al. 2020. "DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia" International Journal of Molecular Sciences 21, no. 20: 7663. https://doi.org/10.3390/ijms21207663

Szoltysek, K., Ciardullo, C., Zhou, P., Walaszczyk, A., Willmore, E., Rand, V., Marshall, S., Hall, A., J. Harrison, C., Eswaran, J., & Soundararajan, M. (2020). DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences, 21(20), 7663. https://doi.org/10.3390/ijms21207663